Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,774,702
  • Shares Outstanding, K 56,621
  • Annual Sales, $ 1,891 M
  • Annual Income, $ 447,100 K
  • 60-Month Beta 1.11
  • Price/Sales 3.63
  • Price/Cash Flow 7.23
  • Price/Book 2.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 3.19
  • Number of Estimates 6
  • High Estimate 3.29
  • Low Estimate 3.11
  • Prior Year 3.23
  • Growth Rate Est. (year over year) -1.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.52 +3.90%
on 10/14/19
134.00 -9.65%
on 09/25/19
-8.14 (-6.30%)
since 09/20/19
3-Month
116.52 +3.90%
on 10/14/19
142.80 -15.22%
on 07/31/19
-15.55 (-11.38%)
since 07/19/19
52-Week
113.52 +6.65%
on 12/24/18
165.66 -26.92%
on 11/02/18
-34.92 (-22.39%)
since 10/19/18

Most Recent Stories

More News
Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out?

Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

ZTS : 126.45 (-1.30%)
JAZZ : 121.07 (+1.19%)
UTHR : 84.03 (+2.30%)
NBIX : 97.27 (+1.56%)
Jazz Starts CAR T-cell Linked Neurotoxicity Study Enrollment

Jazz (JAZZ) enrolls first patient in a mid-stage study to evaluate defibrotide in prevention of neurotoxicity in relapsed/refractory DLBCL patients receiving CAR T-cell therapy.

BLUE : 91.48 (+2.18%)
ZIOP : 4.14 (+4.94%)
GILD : 65.21 (+0.46%)
JAZZ : 121.07 (+1.19%)
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity

Jazz Pharmaceuticals plc today announced that the first patient has been enrolled in an exploratory Phase 2 clinical trial evaluating the ability of defibrotide to prevent neurotoxicity in patients with...

JAZZ : 121.07 (+1.19%)
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in an exploratory Phase 2 clinical trial evaluating the ability of defibrotide to prevent neurotoxicity...

JAZZ : 121.07 (+1.19%)
5 High Earnings Yield Stocks to Buy for a Rewarding Portfolio

Here are five stocks with high earnings yield that can be picked for a solid portfolio.

MTH : 74.80 (-0.27%)
JAZZ : 121.07 (+1.19%)
GES : 17.26 (+1.41%)
AMEH : 14.94 (+0.95%)
VST : 27.05 (+0.97%)
Jazz Pharmaceuticals Enters Oversold Territory

Jazz Pharmaceuticals plc (JAZZ) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

JAZZ : 121.07 (+1.19%)
JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 121.07 (+1.19%)
ZTS : 126.45 (-1.30%)
Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the results of a consumer survey of more than 1,000 Americans measuring public perception and knowledge of sleep disorders like narcolepsy. Narcolepsy...

JAZZ : 121.07 (+1.19%)
Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that positive data from the Phase 3 study of its investigational medicine, JZP-258, for the treatment of cataplexy and excessive daytime sleepiness...

JAZZ : 121.07 (+1.19%)
Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

JAZZ : 121.07 (+1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade JAZZ with:

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

2nd Resistance Point 123.57
1st Resistance Point 122.32
Last Price 121.07
1st Support Level 119.55
2nd Support Level 118.02

See More

52-Week High 165.66
Fibonacci 61.8% 145.74
Fibonacci 50% 139.59
Fibonacci 38.2% 133.44
Last Price 121.07
52-Week Low 113.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar